Cargando…
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Exhaled nitric oxide fraction (F(ENO)) values can be easily measured using portable analysers and are a surrogate marker of airway eosinophilia. F(ENO) may be useful in diagnosing and monitoring conditions characterised by airway eosinophilia, i.e. asthma and possibly COPD. Many factors other than a...
Autores principales: | Turner, Steve W., Chang, Anne B., Yang, Ian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885348/ https://www.ncbi.nlm.nih.gov/pubmed/31803265 http://dx.doi.org/10.1183/20734735.0268-2019 |
Ejemplares similares
-
Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016) -
Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018) -
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review
por: Essat, Munira, et al.
Publicado: (2016)